![]() |
市场调查报告书
商品编码
1890755
脉搏血氧仪探头市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2024-2032)Pulse Oximeter Probes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
随着呼吸健康监测成为现代医疗保健系统的重要组成部分,全球脉搏血氧仪探头市场持续扩张。 2024年,市场规模达到27亿美元,主要驱动因素包括呼吸系统和心血管疾病的增加、外科手术数量的增长以及人口老化。非侵入性患者监测技术的进步和家庭医疗保健的兴起也加速了产品的普及。预计到2025年,市场规模将成长至30.2亿美元,反映出医院、门诊手术中心和家庭医疗保健机构的强劲需求。到2032年,市场规模预计将达到69.9亿美元,预测期内复合年增长率(CAGR)为12.7%。
北美将继续保持其领先区域市场的地位,预计到 2024 年将占 59.26% 的市场占有率。这主要得益于先进患者监护系统的广泛应用、慢性阻塞性肺病 (COPD) 和心臟病的高发病率以及完善的医疗保健基础设施。 Masimo、美敦力、飞利浦和 Nonin 等主要厂商的存在,也进一步巩固了该地区的领先地位。
市场动态
驱动因素:呼吸系统疾病日益增加
慢性呼吸道疾病(例如 COPD、气喘、肺癌、睡眠呼吸中止症和先天性心臟病)在全球的盛行率不断上升,持续推动对精准血氧饱和度监测的需求。例如,根据美国的数据,大约每 100 名婴儿中就有 1 名患有先天性心臟病 (CHD),其中 25% 的患儿被诊断为重度先天性心臟病,需要持续进行 SpO2 监测。 患者数量的增加凸显了脉搏血氧仪探头在医院、急诊护理和家庭医疗保健环境中的关键作用。新冠肺炎疫情进一步提高了全球对氧气监测的认识,推动了脉搏血氧仪在2020年至2021年间的空前普及。随后,市场在2022年趋于正常,并在2023年第三季强劲復苏。
限制因素:数位化替代方案的崛起
市场面临来自新兴技术的压力,例如配备血氧饱和度感测器的智慧手錶、基于智慧型手机的监测应用程式以及具有多重追踪功能的可穿戴健康设备。苹果、三星和Alphabet等公司正在加速将氧气测量功能整合到消费性电子设备中,这给传统的脉搏血氧仪探头带来了激烈的竞争。
挑战:准确性与监管
人们仍然对准确性感到担忧,尤其是在肤色较深的人群中。 根据FDA的调查结果,脉搏血氧仪读数低于90%的情况差异很大,实际饱和度可能在86%到94%之间。监管机构正在製定更严格的指导方针,迫使製造商提高探头的灵敏度和校准技术。
机会:新兴经济体医疗保健基础设施的扩展
像印度这样的国家正在大力投资医疗保健现代化,政府已宣布一项68亿美元的信贷激励计划,以扩展基础设施。这些措施正在推动对包括脉搏血氧仪探头在内的监测设备的需求,为全球和本地製造商创造长期机会。
市场趋势
探头技术的进步,包括无线连接、人工智慧赋能的精准度以及与行动装置的增强相容性,正在重塑市场格局。 BioIntelliSense 获得 FDA 批准的 SpO2 晶片组等创新产品,能够针对各种肤色和患者活动提供精准的读数,凸显了业界向更智慧、更可靠的监测工具转型的趋势。
远距病患监护、远距医疗和家庭护理的兴起进一步推动了对易于使用的消费级探头的需求。医院和诊所也不断升级到更先进的可重复使用和一次性感测器系统,以提高感染控制和诊断准确性。
2024 年,可重复使用探头凭藉其耐用性、成本效益和在大型医疗机构的广泛应用,占了最大的市场占有率。随着医院将感染控制放在首位,一次性探头的市场占有率正在迅速增长。
成年人是最大的年龄族群,这主要是由于慢性阻塞性肺病 (COPD) 和心臟病的高发生率。 同时,儿科对新生儿监护的需求持续成长。
在测量部位方面,指尖探头因其易用性、价格优势以及在各种医疗环境中的广泛适用性,在2024年占主导地位。
医院和门诊手术中心继续保持其作为主要终端使用者的地位,这得益于手术量和重症监护病房入院人数的增长。
到2024年,北美将占全球市场10.6亿美元的占有率,凭藉其先进监护技术的高普及率,继续保持领先地位。
欧洲将占相当大的占有率,这得益于其强大的临床基础设施和日益加重的慢性病负担。
亚太地区是成长最快的地区,这得益于医疗保健的快速发展、重症监护病房容量的增加以及呼吸系统疾病病例的增加。
在医疗保健投资不断扩大的支持下,拉丁美洲、中东和非洲预计将保持稳定成长。
细分:年龄层、最终用户、测量尺寸、最终用户、地区
依产品类型
依年龄组
按测量部位
按最终使用者
按地区
The global pulse oximeter probes market continues to expand as respiratory health monitoring becomes a critical part of modern healthcare systems. In 2024, the market was valued at USD 2.70 billion, driven by the increasing prevalence of respiratory and cardiovascular diseases, higher surgical volumes, and a rising elderly population. Advancements in non-invasive patient monitoring technologies and the shift toward home-based care have also accelerated product adoption. In 2025, the market is projected to grow to USD 3.02 billion, reflecting strong demand across hospitals, ambulatory surgery centers, and home healthcare settings. By 2032, the market is expected to reach USD 6.99 billion, exhibiting a strong CAGR of 12.7% during the forecast period.
North America remained the dominant regional market in 2024 with a 59.26% market share, supported by widespread adoption of advanced patient monitoring systems, high prevalence of COPD and cardiac diseases, and well-established healthcare infrastructure. The presence of major companies-including Masimo, Medtronic, Philips, and Nonin-continues to strengthen the region's leadership position.
Market Dynamics
Drivers: Rising Burden of Respiratory Diseases
The increasing global prevalence of chronic respiratory conditions such as COPD, asthma, lung cancer, sleep apnea, and congenital heart defects continues to drive demand for accurate oxygen saturation monitoring. For instance, U.S. data shows that CHDs affect roughly one in 100 infants, with 25% diagnosed with critical congenital heart defects requiring continuous SpO2 monitoring. This rising patient volume underscores the essential role of pulse oximeter probes in hospitals, emergency care, and home health setups. The COVID-19 pandemic further expanded global awareness of oxygen monitoring, leading to unprecedented adoption of pulse oximeters during 2020-2021 before the market normalized in 2022 and recovered strongly by Q3 2023.
Restraints: Emergence of Digital Alternatives
The market faces pressure from emerging technologies such as smartwatches with SpO2 sensors, smartphone-based monitoring apps, and wearable health devices capable of multi-parameter tracking. Companies like Apple, Samsung, and Alphabet have accelerated the integration of oxygen measurement into consumer devices, creating strong competition for traditional pulse oximeter probes.
Challenges: Accuracy and Regulatory Scrutiny
Accuracy concerns-particularly for individuals with darker skin pigmentation-remain a challenge. According to FDA insights, pulse oximeter readings below 90% can vary considerably, with true saturation levels ranging between 86-94%. Regulatory bodies are working toward stricter guidelines, prompting manufacturers to improve probe sensitivity and calibration technology.
Opportunities: Expanding Healthcare Infrastructure in Emerging Economies
Countries such as India are investing heavily in healthcare modernization, with the government announcing a USD 6.8 billion credit incentive program for infrastructure expansion. Such initiatives are boosting demand for monitoring devices, including pulse oximeter probes, creating long-term opportunities for global and local manufacturers.
Market Trends
Advancements in probe technology-such as wireless connectivity, AI-enhanced accuracy, and improved compatibility with mobile devices-are reshaping the market. Innovations such as BioIntelliSense's FDA-cleared SpO2 chipset, capable of accurate readings across diverse skin tones and during patient movement, highlight the industry's shift toward smarter, more reliable monitoring tools.
The rise in remote patient monitoring, telehealth, and home-based care is further supporting demand for consumer-friendly probes. Hospitals and clinics also continue upgrading to more advanced reusable and disposable sensor systems to improve infection control and diagnostic precision.
The reusable probe segment accounted for the largest share in 2024 due to durability, cost-efficiency, and widespread use in high-volume healthcare facilities. Disposable probes are growing rapidly as hospitals prioritize infection control.
Adults constituted the largest age-group segment, driven by high COPD and cardiac disease incidence, while pediatric demand continues to rise for neonatal monitoring.
Finger-based probes dominated the measurement site segment in 2024 due to ease of use, affordability, and broad suitability across care settings.
Hospitals and ambulatory surgery centers remained the leading end-user segment, supported by rising surgical volumes and intensive care admissions.
North America accounted for USD 1.06 billion of the global value in 2024, maintaining leadership due to high adoption of advanced monitoring technologies.
Europe holds a significant share, backed by a strong clinical infrastructure and rising chronic disease burden.
Asia Pacific is the fastest-growing region due to rapid healthcare development, increasing ICU capacity, and growing respiratory disease cases.
Latin America and the Middle East & Africa are witnessing steady growth supported by expanding healthcare investments.
Conclusion
With the market advancing from USD 2.70 billion in 2024 to a projected USD 6.99 billion by 2032, pulse oximeter probes will remain integral to global patient monitoring. Rising chronic diseases, technological innovation, and expansion of home healthcare services position this market for strong, sustained growth throughout the forecast period.
Segmentation Age Group, End-User, Measurement Size, End-user, and Region
By Product Type * Disposable
By Age Group * Adults
By Measurement Site * Forehead
By End-user * Hospitals and ASCs
By Geography * North America (By Product Type, By Age Group, By Measurement Site, By End-user, and By Country)